ABVC BioPharma (ABVC) Q1 2026 Earnings

18MayConfirmed
Q3 2025
Q4 2025
Q4 2025
Q1 2026
-0.16
-0.13
-0.09
-0.06

Details

Expected EPS
N/A
Actual EPS
-0.06
Surprise EPS
-0.06
Surprise Percent
+∞%

Description

ABVC BioPharma (ABVC) has reported earnings of -0.06 per share for Q1 2026.

0 Comments

Share your thoughts